Alnylam Pharmaceuticals | Lucro Operacional

Operating Profit Alterar Data
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
Arrowhead Research USD -136545000 28.22M 2023-12
Avrobio USD -22933000 90.94M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Incyte USD 187.27M 27.44M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Takeda JPY -49342000000 217.91B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09
Xencor USD -35009000 16.74M 2023-12



Alnylam Pharmaceuticals Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.